Cargando…
TangShenWeiNing Formula Prevents Diabetic Nephropathy by Protecting Podocytes Through the SIRT1/HIF-1α Pathway
BACKGROUND: Diabetic nephropathy (DN) represents a major complication of diabetes, and podocyte injury has a critical function in DN development. TangShenWeiNing formula (TSWN) has been demonstrated to efficiently decrease proteinuria and protect podocytes in DN. This work aimed to explore the mecha...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204479/ https://www.ncbi.nlm.nih.gov/pubmed/35721758 http://dx.doi.org/10.3389/fendo.2022.888611 |
_version_ | 1784728936024899584 |
---|---|
author | Chang, Jing Zheng, Jinsu Gao, Xia Dong, Hengbei Yu, Haitian Huang, Mengxiu Sun, Zhencheng Feng, Xiaomeng |
author_facet | Chang, Jing Zheng, Jinsu Gao, Xia Dong, Hengbei Yu, Haitian Huang, Mengxiu Sun, Zhencheng Feng, Xiaomeng |
author_sort | Chang, Jing |
collection | PubMed |
description | BACKGROUND: Diabetic nephropathy (DN) represents a major complication of diabetes, and podocyte injury has a critical function in DN development. TangShenWeiNing formula (TSWN) has been demonstrated to efficiently decrease proteinuria and protect podocytes in DN. This work aimed to explore the mechanism by which TSWN alleviates DN and protects podocytes. METHODS: The major bioactive components of TSWN were detected by mass spectrometry (MS) and pharmacological databases. Eight-week-old male C57BLKS/J db/m and db/db mice were provided pure water, valsartan, low dose TSWN, middle dose TSWN and high dose TSWN by gavage for 12 weeks, respectively. RESULTS: MS and network pharmacology analyses suggested that TSWN might prevent DN through the sirtuin (SIRT)1/hypoxia-inducible factor (HIF)-1α pathway. Diabetic mice showed elevated urinary albumin in comparison with non-diabetic mice, and TSWN decreased urinary albumin in diabetic mice. Histological injury increased in the kidney in diabetic mice, which could be improved by TSWN. Fibrosis and collagen I expression were induced in the diabetic mouse kidney in comparison with the non-diabetic mouse kidney; TSWN alleviated these effects. Apoptosis and cleaved caspase-3 were induced in the diabetic mouse kidney in comparison with the non-diabetic mouse kidney, and TSWN blunted these effects. Podocytes were damaged in the diabetic mouse kidney, which was improved by TSWN. Podocin and nephrin amounts were decreased in the diabetic mouse kidney in comparison with the non-diabetic mouse kidney, and podocalyxin was increased in urine of diabetic animals in comparison with non-diabetic counterparts. After TSWN treatment, podocin and nephrin were raised in the diabetic mouse kidney, and urinary podocalyxin was depressed in diabetic animals. Diabetic mice had lower SIRT1 and higher HIF-1α amounts in kidney specimens in comparison with non-diabetic mice, and TSWN promoted SIRT1 and inhibited HIF-1α in the diabetic mouse kidney. Moreover, co-staining of SIRT1 and podocin revealed that SIRT1 decreased in podocytes from diabetic mice in comparison with those from non-diabetic mice, and TSWN elevated SIRT1 in podocytes. CONCLUSIONS: This study indicated that TSWN alleviates DN by improving podocyte injury through the SIRT1/HIF-1α pathway in diabetic mouse kidneys. |
format | Online Article Text |
id | pubmed-9204479 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92044792022-06-18 TangShenWeiNing Formula Prevents Diabetic Nephropathy by Protecting Podocytes Through the SIRT1/HIF-1α Pathway Chang, Jing Zheng, Jinsu Gao, Xia Dong, Hengbei Yu, Haitian Huang, Mengxiu Sun, Zhencheng Feng, Xiaomeng Front Endocrinol (Lausanne) Endocrinology BACKGROUND: Diabetic nephropathy (DN) represents a major complication of diabetes, and podocyte injury has a critical function in DN development. TangShenWeiNing formula (TSWN) has been demonstrated to efficiently decrease proteinuria and protect podocytes in DN. This work aimed to explore the mechanism by which TSWN alleviates DN and protects podocytes. METHODS: The major bioactive components of TSWN were detected by mass spectrometry (MS) and pharmacological databases. Eight-week-old male C57BLKS/J db/m and db/db mice were provided pure water, valsartan, low dose TSWN, middle dose TSWN and high dose TSWN by gavage for 12 weeks, respectively. RESULTS: MS and network pharmacology analyses suggested that TSWN might prevent DN through the sirtuin (SIRT)1/hypoxia-inducible factor (HIF)-1α pathway. Diabetic mice showed elevated urinary albumin in comparison with non-diabetic mice, and TSWN decreased urinary albumin in diabetic mice. Histological injury increased in the kidney in diabetic mice, which could be improved by TSWN. Fibrosis and collagen I expression were induced in the diabetic mouse kidney in comparison with the non-diabetic mouse kidney; TSWN alleviated these effects. Apoptosis and cleaved caspase-3 were induced in the diabetic mouse kidney in comparison with the non-diabetic mouse kidney, and TSWN blunted these effects. Podocytes were damaged in the diabetic mouse kidney, which was improved by TSWN. Podocin and nephrin amounts were decreased in the diabetic mouse kidney in comparison with the non-diabetic mouse kidney, and podocalyxin was increased in urine of diabetic animals in comparison with non-diabetic counterparts. After TSWN treatment, podocin and nephrin were raised in the diabetic mouse kidney, and urinary podocalyxin was depressed in diabetic animals. Diabetic mice had lower SIRT1 and higher HIF-1α amounts in kidney specimens in comparison with non-diabetic mice, and TSWN promoted SIRT1 and inhibited HIF-1α in the diabetic mouse kidney. Moreover, co-staining of SIRT1 and podocin revealed that SIRT1 decreased in podocytes from diabetic mice in comparison with those from non-diabetic mice, and TSWN elevated SIRT1 in podocytes. CONCLUSIONS: This study indicated that TSWN alleviates DN by improving podocyte injury through the SIRT1/HIF-1α pathway in diabetic mouse kidneys. Frontiers Media S.A. 2022-05-26 /pmc/articles/PMC9204479/ /pubmed/35721758 http://dx.doi.org/10.3389/fendo.2022.888611 Text en Copyright © 2022 Chang, Zheng, Gao, Dong, Yu, Huang, Sun and Feng https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Chang, Jing Zheng, Jinsu Gao, Xia Dong, Hengbei Yu, Haitian Huang, Mengxiu Sun, Zhencheng Feng, Xiaomeng TangShenWeiNing Formula Prevents Diabetic Nephropathy by Protecting Podocytes Through the SIRT1/HIF-1α Pathway |
title | TangShenWeiNing Formula Prevents Diabetic Nephropathy by Protecting Podocytes Through the SIRT1/HIF-1α Pathway |
title_full | TangShenWeiNing Formula Prevents Diabetic Nephropathy by Protecting Podocytes Through the SIRT1/HIF-1α Pathway |
title_fullStr | TangShenWeiNing Formula Prevents Diabetic Nephropathy by Protecting Podocytes Through the SIRT1/HIF-1α Pathway |
title_full_unstemmed | TangShenWeiNing Formula Prevents Diabetic Nephropathy by Protecting Podocytes Through the SIRT1/HIF-1α Pathway |
title_short | TangShenWeiNing Formula Prevents Diabetic Nephropathy by Protecting Podocytes Through the SIRT1/HIF-1α Pathway |
title_sort | tangshenweining formula prevents diabetic nephropathy by protecting podocytes through the sirt1/hif-1α pathway |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204479/ https://www.ncbi.nlm.nih.gov/pubmed/35721758 http://dx.doi.org/10.3389/fendo.2022.888611 |
work_keys_str_mv | AT changjing tangshenweiningformulapreventsdiabeticnephropathybyprotectingpodocytesthroughthesirt1hif1apathway AT zhengjinsu tangshenweiningformulapreventsdiabeticnephropathybyprotectingpodocytesthroughthesirt1hif1apathway AT gaoxia tangshenweiningformulapreventsdiabeticnephropathybyprotectingpodocytesthroughthesirt1hif1apathway AT donghengbei tangshenweiningformulapreventsdiabeticnephropathybyprotectingpodocytesthroughthesirt1hif1apathway AT yuhaitian tangshenweiningformulapreventsdiabeticnephropathybyprotectingpodocytesthroughthesirt1hif1apathway AT huangmengxiu tangshenweiningformulapreventsdiabeticnephropathybyprotectingpodocytesthroughthesirt1hif1apathway AT sunzhencheng tangshenweiningformulapreventsdiabeticnephropathybyprotectingpodocytesthroughthesirt1hif1apathway AT fengxiaomeng tangshenweiningformulapreventsdiabeticnephropathybyprotectingpodocytesthroughthesirt1hif1apathway |